Диссертация (1154746), страница 20
Текст из файла (страница 20)
– P. 89-98.263. Schrul B., Kapp K., Sinning I., Dobberstein B. Signal peptide peptidase(SPP) assembles with substrates and misfolded membrane proteins into distinctoligomeric complexes // Biochem J. – 2010, - V. 427, N 3. – P. 523–534.264. Seidah N.G., Chretien M. Proprotein and prohormone convertases of thesubtilisin family - recent developments and future perspectives // TrendsEndocrinol.
Met. – 1992. – 3, N 4. – P. 133-140.265. Selicharova I., Sanda M., Mladkova J., Ohri S.S., Vashishta A., Fusek M.,Jiracek J., Vetvicka V. 2-DE analysis of breast cancer cell lines 1833 and 4175with distinct metastatic organ-specific potentials: comparison with parental cellline MDA-MB-231 // Oncol Rep. 2008. N 19 (5). p. 1237-1244.266. Shaw C. Neuropeptides and their evolution // Parasitology.
– 1996. – 113. –P. S35–S45.267. Sheng Y., Xu J., You Y., Xu F., Chen Y. Acid-Sensitive Peptide-ConjugatedDoxorubicin Mediates the Lysosomal Pathway of Apoptosis and Reverses DrugResistance in Breast Cancer // Mol Pharm. 2015. N 12(7). p. 2217-2228.127268. Shimamura M., Hazato T., Iwaguchi T. A new aminopeptidase in monkeycerebral membrane fraction: hydrolysis of enkephalin // Brain Res.
– 1988. – 445.– P. 350-353.269. Shtatland T., Guettler D., Kossodo M. Pivovarov M., Weissleder R.PepBank - a database of peptides based on sequence text mining and public peptidedata sources // BMC Bioinformatics. – 2007. – N 8. – P. 280-290.270. Skidgel R.A., Erdös E.G. Structure and function of human plasmacarboxypeptidase N, the anaphylatoxin inactivator // Int Immunopharmacol. –2007, - V 7, - N 14. – P.
1888-1899.271. Skidgel R.A., Erdos E.G. The broad substrate specificity of humanangiotensin I converting enzyme // Clin. Exp. Hypertens. – 1987. – A9, N 2/3. – P.243-259.272. Smyth D.G., Maruthainar K., Darby N.J., Fricker L.D. Catalysis of slow Cterminal processing reactions by carboxypeptidase H // J. Neurochem. – 1989. –53, N 2. – P. 489-493.273. Song C., Phillips A.G., Leonard B. Interleukin 1 beta enhances conditionedfear memory in rats: possible involvement of glucocorticoids // Eur J Neurosci. –2003, - V 18, - N 7.
– P. 1739-1743.274. Song L.X., Fricker L. Processing of procarboxypeptidase E intocarboxypeptidase E occurs in secretory vesicles // J. Neurochem. – 1995. – 65, N 1,P. 444-453.275. Steiner D.F. The biosynthesis of biologically active peptides: a perspective //Peptide Biosynthesis and Processing (Fricker L.D., ed.).– CRC Press, Boca Raton,Florida, 1991.– P. 1-16.276.
Stoka V., Turk V., Turk B. Lysosomal cathepsins and their regulation inaging and neurodegeneration // Ageing Res Rev. 2016.N 26. pii: S1568-1637 (16).p. 30067-30068277. Su S., Zhu X., Lin L., Chen X., Wang Y., Zi J., et al. Lowering endogenouscathepsin D abundance results in ROS accumulation and cell senescence // MolCell Proteomics. 2015. pii: mcp.M115.050179.128278. Supattapone S., Fricker L.D., Snyder S.H.
Purification and characterizationof a membrane-boundenkephalin-forming carboxypeptidase, «enkephalinconvertase» // Neurochem. – 1984. – 42, N 4. – P. 1017-1023.279. Takayanagi Y., Onaka T. Roles of prolactin-releasing peptide and RFamiderelated peptides in the control of stress and food intake // FEBS J. – 2010, - V 277,- N 24. – P. 4998-5005.280. Tang H.Y., Beer L.A., Chang-Wong T., Hammond R., Gimotty P., CoukosG., Speicher D.W. A xenograft mouse model coupled with in-depth plasmaproteome analysis facilitates identification of novel serum biomarkers for humanovarian cancer // J Proteome Res. 2012. N 3; 11 (2).
p. 678-91.281. Tetsuji H., Kenji T. Purification and charasterization of a calcium-activatedneutral protease from monkey brain and its action on neuropeptides // J. Biochem.– 1984. – 96, N 3. – P. 775-784.282. Têtu B., Brisson J., Lapointe H., Wang C.S., Bernard P., Blanchette C.,Cathepsin D expression by cancer and stromal cells in breast cancer: animmunohistochemical study of 1348 cases // Breast Cancer Res. Treat. 1999, 55 р.137–147.283. Thelen M. Dancing to the tune of chemokines // Nat.
Immunol. – 2001, - V2. – P. 129-134.284. Tiwari R.V., Parajuli P., Sylvester P.W. Synergistic anticancer effects ofcombined γ-tocotrienol and oridonin treatment is associated with the induction ofautophagy // Mol Cell Biochem. 2015. N 408 (1-2). p. 123-137.285. Tsujimura A, Taguchi K, Watanabe Y, Tatebe H, Tokuda T, Mizuno T,Tanaka M. Lysosomal enzyme cathepsin B enhances the aggregate formingactivity of exogenous α-synuclein fibrils // Neurobiol Dis.
2015, N 73. p 244-253.286. Umezawa H., Aoyagi T., Morishima H., Matsuzaki M., Hamada M.,Takeuchi T. Pepstatin, a new pepsin inhibitor produced by Actinomycetes // J.Antibiot. 1970. N 23. p. 259–262.287. Vega A., Luther J.A., Birren S.J., Morales M.A. Segregation of the classicaltransmitters norepinephrine and acetylcholine and the neuropeptide Y in129sympathetic neurons: modulation by ciliary neurotrophic factor or prolongedgrowth in culture // Dev Neurobiol.
– 2010, - V 70, - N 14. – P. 913-928.288. Vetvicka V, Fusek M. Cathepsin D: Autoantibody profiling as a diagnosticmarker for cancers // World J Clin Oncol. 2013. N 10. V 4. p. 1-3.289. Vezenkov L.L., Sanchez C.A., Bellet V., Martin V., Maynadier M., BettacheN., Lisowski V., Martinez J., Garcia M., Amblard M., Hernandez J.F.
StructureActivity Relationships of JMV4463, a Vectorized Cathepsin D Inhibitor withAntiproliferative Properties: The Unique Role of the AMPA-Based Vector //ChemMedChem. 2016, N 11 (3), p. 302-308.290. Westley B.R., May F.E. Prognostic value of cathepsin D in breast cancer //Br. J.
Cancer. 1999. N 79. p. 189–190.291. Wilhelm J., Heberlein A., Karagülle D., Gröschl M., Kornhuber J., Riera R.,Frieling H., Bleich S., Hillemacher T. Prolactin serum levels during alcoholwithdrawal are associated with the severity of alcohol dependence and withdrawalsymptoms // Alcohol Clin.
Exp. Res. – 2011, - V 35, - N 2. – P. 235-239.292. Wilk S., Wilk E., Magnusson R.P. Purification, characterization, and cloningof a cytosolic aspartyl aminopeptidase // J. Biol. Chem. – 1998. – 273, N 26. – P.15961-15970.293. Willemse J.L., Hendriks D.F. A rapid and sensitive assay for the quantitationof carboxypeptidase N, an important regulator of inflammation // Clin Chim Acta.– 2006, - V 371, - N 1-2. – P. 124-129.294. Willemse J.L., Polla M., Olsson T., Hendriks D.F.
Comparative substratespecificity study of carboxypeptidase U (TAFIa) and carboxypeptidase N:development of highly selective CPU substrates as useful tools for assaydevelopment // Clin. Chim. Acta. – 2008, - V 387, - N 1-2. – P. 158-160.295. Wirth M.J., Brun A., Grabert J., Patz S., Wahle P. Accelerated dendriticdevelopment of rat cortical pyramidal cells and interneurons after biolistictransfection with BDNF and NT4/5 // Development. – 2003, - V 130, - N 23. – P.5827-5838.130296.
Yamamoto H., Yamada T., Takabayashi T., Sunaga H., Oh M., Narita N.,Kojima A., Fujieda S. Platelet Derived Endothelial Cell Growth Factor/ThymidinePhosphorylase Enhanced Human IgE Production // Allergol Int. – 2011, - V 60, N 1. – P. 79-85.297. Yamamoto M., Ito Y., Mitsuma N., Hattori N., Sobue G. Pain-relateddifferential expression of NGF, GDNF, IL-6, and their receptors in humanvasculitic neuropathies // Intern Med. – 2003, - V 42, - N 11.
– P. 1100-1103.298. Yamashita T., Shimada H., Tanaka S., Araki K., Tomifuji M., Mizokami D.,et. al. Serum midkine as a biomarker for malignancy, prognosis, andchemosensitivity in head and neck squamous cell carcinoma // Cancer Med. 2016.N 5(3). p. 415-425.299. Yang C.L., Liu Y.Y., Zhang Q., Ran L., Zhang Z., Jiang R. The preclinicalevaluation of TIC10/ONC201 as an anti-pancreatic cancer agent // BiochemBiophys Res Commun. 2016. N 24. pii: S0006-291X(16 p. )30814-30822.300. Yang Z., Bagheri-Yarmand R., Wang R.A., Adam L., PapadimitrakopoulouV.V., Clayman G.L. The Epidermal Growth Factor Receptor Tyrosine KinaseInhibitor ZD1839 (Iressa) Suppresses c-Src and Pak1 Pathways and Invasivenessof Human Cancer Cells // Clin.
Cancer Res. – 2004, - V 10, - N 2. – P. 658-667.301. Železnik T.Z., Puizdar V., Dolenc I. Expression, purification and autoactivation of cathepsin E from insect cells // Protein Pept Lett. 2015, 22(6). p. 52531.302. Zhang J., Jin Y., Xu S., Zheng J., Zhang Q.I., et. al. AGR2 is associated withgastric cancer progression and poor survival // Oncol Lett. 2016. N 11 (3). p. 20752083.303. Zheng N., Wei W., Wang Z. Emerging roles of FGF signaling inhepatocellular carcinoma // Transl Cancer Res. 2016. N 5(1). p. 1-6.304. Zhou K, Liang H, Liu Y, Yang C, Liu P, Jiang X. Overexpression of CPEΔN predicts poor prognosis in colorectal cancer patients // Tumour Biol.
2013Dec;34(6):3691-3699.131305. Ziegler S.G., Thornton J.E. Low luteinizing hormone enhances spatialmemory and has protective effects on memory loss in rats // Horm Behav. – 2010, V 58, - N 5. – P. 705-713.306. Zou K., Yamaguchi H., Akatsu H., Sakamoto T., Ko M., Mizoguchi K.,Gong J.S., Yu W., Yamamoto T., Kosaka K., Yanagisawa K., Michikawa M.Angiotensin-converting enzyme converts amyloid beta-protein 1-42 (Abeta(1-42))to Abeta(1-40), and its inhibition enhances brain Abeta deposition // J Neurosci.
–2007, - V 27, - N 32. – P. 8628-8635.307. Zou Q., Cui D., Liang S., Xia S., Jing Y., Han B. Aging up-regulatesARA55 in stromal cells, inducing androgen-mediated prostate cancer cellproliferation and migration // J Mol Histol. 2016. N 47 (3). p. 305-315..
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
